FDA Approves XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy Read more about FDA Approves XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior TherapyAdd new comment
NCCN Adds Three XPOVIO® (selinexor) Treatment Regimens to Its Clinical Practice Guidelines in Oncology for Multiple Myeloma Read more about NCCN Adds Three XPOVIO® (selinexor) Treatment Regimens to Its Clinical Practice Guidelines in Oncology for Multiple MyelomaAdd new comment
Charity Navigator Awards IMF a 4-Star Rating for the 16th Time Read more about Charity Navigator Awards IMF a 4-Star Rating for the 16th TimeAdd new comment
The International Myeloma Working Group (IMWG) New Risk Stratification Model for Smoldering Myeloma Will Reduce Risk of Disease Progression and End-Organ Damage Read more about The International Myeloma Working Group (IMWG) New Risk Stratification Model for Smoldering Myeloma Will Reduce Risk of Disease Progression and End-Organ DamageAdd new comment
The International Myeloma Foundation Honors Cancer Researchers Thierry Facon and Wee Joo Chng for Their Extraordinary Contributions Read more about The International Myeloma Foundation Honors Cancer Researchers Thierry Facon and Wee Joo Chng for Their Extraordinary ContributionsAdd new comment
FDA Approves Kyprolis in Combination with Darzalex and Dexamethasone for Relapsed or Refractory Myeloma Read more about FDA Approves Kyprolis in Combination with Darzalex and Dexamethasone for Relapsed or Refractory MyelomaAdd new comment
FDA granted accelerated approval to belantamab mafodotin-blmf for multiple myeloma Read more about FDA granted accelerated approval to belantamab mafodotin-blmf for multiple myelomaAdd new comment
CDMRP Myeloma Research Programs Receive Funding Read more about CDMRP Myeloma Research Programs Receive FundingAdd new comment
UPDATE 1-FDA panel votes in favor of approving GSK's multiple myeloma drug Read more about UPDATE 1-FDA panel votes in favor of approving GSK's multiple myeloma drugAdd new comment
